- Phare
 - Validé par KD/KO
 
Anticorps Monoclonal anti-PD-1/CD279
PD-1/CD279 Monoclonal Antibody for IF-P, FC
Hôte / Isotype
Mouse / IgG2b
Réactivité testée
Humain, rat, souris
Applications
IF-P, FC
Conjugaison
CoraLite® Plus 647 Fluorescent Dye
CloneNo.
4H4D1
N° de cat : CL647-66220
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en IF-P | tissu d'amygdalite humain, | 
| Résultats positifs en cytométrie | CMSP humaines, PBMC | 
Dilution recommandée
| Application | Dilution | 
|---|---|
| Immunofluorescence (IF)-P | IF-P : 1:50-1:500 | 
| Flow Cytometry (FC) | FC : 0.20 ug per 10^6 cells in a 100 µl suspension | 
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Applications publiées
| IF | See 1 publications below | 
| FC | See 1 publications below | 
Informations sur le produit
CL647-66220 cible PD-1/CD279 dans les applications de IF-P, FC et montre une réactivité avec des échantillons Humain, rat, souris
| Réactivité | Humain, rat, souris | 
| Réactivité citée | rat, souris | 
| Hôte / Isotype | Mouse / IgG2b | 
| Clonalité | Monoclonal | 
| Type | Anticorps | 
| Immunogène | PD-1/CD279 Protéine recombinante Ag12470 | 
| Nom complet | programmed cell death 1 | 
| Masse moléculaire calculée | 288 aa, 32 kDa | 
| Numéro d’acquisition GenBank | BC074740 | 
| Symbole du gène | PD-1 | 
| Identification du gène (NCBI) | 5133 | 
| Conjugaison | CoraLite® Plus 647 Fluorescent Dye | 
| Excitation/Emission maxima wavelengths | 654 nm / 674 nm | 
| Forme | Liquide | 
| Méthode de purification | Purification par protéine A | 
| Tampon de stockage | PBS with 50% glycerol, 0.05% Proclin300, 0.5% BSA | 
| Conditions de stockage | Stocker à -20 °C. Éviter toute exposition à la lumière. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. | 
Informations générales
Programmed cell death 1 (PD-1, also known as CD279) is an immunoinhibitory receptor that belongs to the CD28/CTLA-4 subfamily of the Ig superfamily. It is a 288 amino acid (aa) type I transmembrane protein composed of one Ig superfamily domain, a stalk, a transmembrane domain, and an intracellular domain containing an immunoreceptor tyrosine-based inhibitory motif (ITIM) as well as an immunoreceptor tyrosine-based switch motif (ITSM) (PMID: 18173375). PD-1 is expressed during thymic development and is induced in a variety of hematopoietic cells in the periphery by antigen receptor signaling and cytokines (PMID: 20636820). Engagement of PD-1 by its ligands PD-L1 or PD-L2 transduces a signal that inhibits T-cell proliferation, cytokine production, and cytolytic function (PMID: 19426218). It is critical for the regulation of T cell function during immunity and tolerance. Blockade of PD-1 can overcome immune resistance and also has been shown to have antitumor activity (PMID: 22658127; 23169436). The calculated molecular weight of PD-1 is 32 kDa. It has been reported that PD-1 is heavily glycosylated and migrates with an apparent molecular mass of 47-55 kDa on SDS-PAGE (PMID: 8671665; 17640856; 17003438).
Protocole
| Product Specific Protocols | |
|---|---|
| IF protocol for CL Plus 647 PD-1/CD279 antibody CL647-66220 | Download protocol | 
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols | 
Publications
| Species | Application | Title | 
|---|---|---|
Clin Cancer Res 18F-FMISO PET Imaging Identifies Hypoxia and Immunosuppressive Tumor Microenvironments and Guides Targeted Evofosfamide Therapy in Tumors Refractory to PD-1 and CTLA-4 Inhibition. | ||
Transplantation Activation of the Aryl Hydrocarbon Receptor Ameliorates Acute Rejection of Rat Liver Transplantation by Regulating Treg Proliferation and PD-1 Expression. | 


